n-leucyldoxorubicin has been researched along with Glial Cell Tumors in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berry, DJ; Cobb, SL; Falconer, RA; Gill, JH; Harburn, JJ; Jain, M; Loadman, PM; Mooney, CA | 1 |
1 other study(ies) available for n-leucyldoxorubicin and Glial Cell Tumors
| Article | Year |
|---|---|
Rationalized Computer-Aided Design of Matrix-Metalloprotease-Selective Prodrugs.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Computer-Aided Design; Drug Design; Glioma; Humans; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Molecular Docking Simulation; Prodrugs | 2017 |